Back to results
Bibliographic record · Consultation and access
Artículo de revista

EFFECTS OF LOSARTAN ON BLOOD PRESSURE AND MICROALBUMINUREA IN HYPERTENSIVE TYPE 2 DIABETIC PATIENTS

Meltem AYLI et al · Turkish Society of Nephrology · 2019

Open-access full text
Quick overview. Review the resource’s basic details, then access the content using the main button. This page shows only the information needed to identify, cite, and open the work.
Serial publication

"ONE HUNDRED AND THIRTY-FIVE HOURS UNDER THE RUIN : A CASE WITH TRAUMATIC RHABDOMYOLYSIS IN GÖLCÜK EARTHQUAKE"

This serial publication contains 1.344 related contents.

Resource access

Open the content from the main option or choose another available source.

DOAJ DOAJ Articles
Entrar por DOAJ
Main access

Open-access full text

Texto completo identificado como acceso abierto.
Open text
Otras opciones de acceso Elegí el proveedor disponible para esta ficha.
DOAJ CSV Export DOAJ - Open Access Journals
Acceder por DOAJ CSV Export
DOAJ OAI-PMH DOAJ Articles
Acceder por DOAJ OAI-PMH

Other available options

When the resource is available on more than one platform, you can choose where to open it.

DOAJ CSV Export DOAJ - Open Access Journals Access available
Open
DOAJ OAI-PMH DOAJ Articles Access available
Open

Summary

Descripción general del contenido del recurso.

Diabetic nephropathy and hypertension are the leading causes of mortalitiy and morbidity in diabetes mellitus type 2 patients. Blockage of renin-angiotensin system with ACE inhibitors, retard the progression of diabetic nephropathy. The aim of this study was to determine the antihypertensive and antimicroalbuminuric effects of losartan in type 2 diabetic and hypertensive patients. 17 diabetics (7 female and JO male, aged 54.8±5.46 ) with hypertension were treated with 50mg/daily of losartan for 12 weeks and followed for the changes in systemic arterial blood pressure, microalbuminuriea and blood biochemistry. Microalbuminuriea decreased to 19.3±2.7mg/dayfrom 5I.4±4.3mg/day (p<0.005) after treatment. Systolic pressure decreased to 132.2±11.4mmHgfwm 156±J5.4 mmHg (p< 0.05) and diastolic pressure decreased to 70.8±15.2 mmHg from 89.3±12.4 mmHg (p< 0.005). Fasting blood glucose , lipids, urea, creatine, derence of creatine and uric acid were not effected unfavourably. In conclusion, losartan reduces blood pressure and microalbuminurea but does not effect the blood biochemistry in hypertensive type II diabetic patients.

How to cite

Elegí el formato que necesitás y copiá la referencia al portapapeles.

APA 7

al, M. A. E. (2019). EFFECTS OF LOSARTAN ON BLOOD PRESSURE AND MICROALBUMINUREA IN HYPERTENSIVE TYPE 2 DIABETIC PATIENTS. https://turkjnephrol.org/index.php/pub/article/view/235

MLA

al, Meltem AYLI et. "EFFECTS OF LOSARTAN ON BLOOD PRESSURE AND MICROALBUMINUREA IN HYPERTENSIVE TYPE 2 DIABETIC PATIENTS." 2019. https://turkjnephrol.org/index.php/pub/article/view/235.

Chicago

al, Meltem AYLI et. 2019. "EFFECTS OF LOSARTAN ON BLOOD PRESSURE AND MICROALBUMINUREA IN HYPERTENSIVE TYPE 2 DIABETIC PATIENTS.". https://turkjnephrol.org/index.php/pub/article/view/235.

Harvard

al, M. A. E. 2019, EFFECTS OF LOSARTAN ON BLOOD PRESSURE AND MICROALBUMINUREA IN HYPERTENSIVE TYPE 2 DIABETIC PATIENTS, Turkish Society of Nephrology, available at: https://turkjnephrol.org/index.php/pub/article/view/235 [Accessed 7 Aug. 2026].

Share and print

Save the record, copy its permanent link, or print it as a PDF.

Export reference

You can export the record in common formats for use in a reference manager.

Resource details

Bibliographic information to help confirm that this is the correct material.

Title
EFFECTS OF LOSARTAN ON BLOOD PRESSURE AND MICROALBUMINUREA IN HYPERTENSIVE TYPE 2 DIABETIC PATIENTS
Author / contributors
Meltem AYLI et al
Publisher
Turkish Society of Nephrology
Publication year
2019
ISSN
2667-4440
ISSN
2667-4440
Language
English

Subjects

Explore related resources through these subjects.

Copied